UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052436
Receipt number R000038240
Scientific Title Early diagnosis of sarcopenia in medical disorders ~Examination of usefulness of biometric data~
Date of disclosure of the study information 2023/10/07
Last modified on 2023/10/07 11:30:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Early diagnosis of sarcopenia in medical disorders
~Examination of usefulness of biometric data~

Acronym

Early diagnosis of sarcopenia in medical disorders
~Examination of usefulness of biometric data~

Scientific Title

Early diagnosis of sarcopenia in medical disorders
~Examination of usefulness of biometric data~

Scientific Title:Acronym

Early diagnosis of sarcopenia in medical disorders
~Examination of usefulness of biometric data~

Region

Japan


Condition

Condition

Neurodegenerative diseases including Parkinson's disease, Parkinson's syndrome, progressive supranuclear palsy.

Classification by specialty

Medicine in general Neurology Geriatrics
Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Establish a diagnostic method for Sarcopenia that can be carried out even by individuals by examining the correlation between the amount of activity measured by the biometric device and the muscle mass using the medical body composition meter and the grip strength and the walking speed.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The amount of activity during sleeping by the biometric device and the degree of agreement between the estimation of sarcopenia and actual occurrence.

Key secondary outcomes

Existence of frail, correlation between muscle mass and activity level.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Before going to bed, the examinee measures muscle mass using a medical body composition meter.

Interventions/Control_2

Attach a biometric measurement device (contact type sensor). Wearing is carried out under the guidance of the experimenter or the experiment collaborator.
The non-contact sensor is operated only overnight (bedtime).
The examinee removes the biometric measuring device at the time of getting up. Removal is performed under the guidance of the experimenter or the experiment collaborator.
A limb wearing type activity meter mounts a band type activity meter (accelerometer) on the left and right wrists, the left and right ankles, or both.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patient group
1.Age: patients aged 20 years or older at the time of acquisition
2.Gender: No prejudice
3.Patients with outpatient visit with neurodegenerative diseases including Parkinson's disease
4.Patients who gained written consent from patients' free will after having sufficient explanation for their participation in this research, with sufficient understanding. Especially when consignment is necessary, decide after consultation.
Control group
1.Age: Subjects aged 20 years or older at the time of consent acquisition
2.Gender: No prejudice
3.After receiving sufficient explanation for participation in this research, after having sufficient understanding, the examinees who obtained document consent by their subjects' free will

Key exclusion criteria

1.Pregnant women and subjects who may be pregnant, or who are breastfeeding
2.Patients who are difficult to stay at general accommodations (hotels, inns, etc.)
3.In addition, subjects whose research managers judged inappropriate as research subjects

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Osamu
Middle name
Last name Yamamura

Organization

University of Fukui

Division name

Regional Medicine Promotion Course, Faculty of Medical Sciences

Zip code

910-1193

Address

23-3 Matsuoka-Shimogetsu Eiheiji-cho, Yoshida-gun, Fukui

TEL

0776-61-8264

Email

t-toku@u-fukui.ac.jp


Public contact

Name of contact person

1st name Osamu
Middle name
Last name Yamamura

Organization

University of Fukui

Division name

Regional Medicine Promotion Course, Faculty of Medical Sciences

Zip code

910-1193

Address

23-3 Matsuoka-Shimogetsu Eiheiji-cho, Yoshida-gun, Fukui

TEL

0776-61-8264

Homepage URL


Email

t-toku@u-fukui.ac.jp


Sponsor or person

Institute

University of Fukui

Institute

Department

Personal name



Funding Source

Organization

Self Funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Fukui

Address

23-3 Matsuoka-Shimogetsu Eiheiji-cho, Yoshida-gun, Fukui

Tel

0776-61-8264

Email

t-toku@u-fukui.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 10 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

90

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 04 Month 01 Day

Date of IRB

2017 Year 04 Month 01 Day

Anticipated trial start date

2018 Year 04 Month 01 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 10 Month 07 Day

Last modified on

2023 Year 10 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000038240


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name